Pacific Biosciences of California Inc. buy The Goldman Sachs Group, Inc.
Start price
10.04.24
/
50%
€3.26
Target price
10.04.25
€6.50
Performance (%)
-62.31%
End price
11.04.25
€1.23
Summary
This prediction ended on 11.04.25 with a price of €1.23. The BUY prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc. performed very badly with a performance of -62.31%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacific Biosciences of California Inc. | 6.132% | 6.132% | 3.556% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€12.81
30.06.23
30.06.23
€15.60
30.06.24
30.06.24
-90.29%
01.07.24
01.07.24
